Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

New alopecia treatments aim for better results and fewer side effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Many adult women suffer from persistent or late-onset acne, and while various treatments exist, finding the right one can be challenging.